knowledge -WSS

knowledge

author：Wikipedia 2025-09-28 02:29:33 - browse：8574

The U.S. Department of Labor claims in a new lawsuit that a UnitedHealth Group unit illegally rejected emergency room care and urine drug screen claims for thousands of people.

UMR, Inc., a Wisconsin-based third-party administrator owned by UnitedHealth, manages benefits for more than 2,100 employee health plans. The federal government says the company denied ER visits and urine drug screens for years using a process that didn’t meet federal standards for health plans that employers fund themselves, known as self-insured plans. The standards are part of a law called the Employee Retirement Income Security Act, or ERISA.

“I see it as significant because the Department of Labor is actually looking under the hood at the standards and methods that insurers apply when they decide whether or not to approve or deny a claim,” said Colleen Medill, a professor at the University of Nebraska College of Law and nationally recognized legal scholar on ERISA. “They are looking at their process.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： The biotech scorecard for Q1: 17 stock

WSS

New weight loss drugs work. But how can they best be used?

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

New weight loss drugs work. But how can they best be used?

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Adidas to release second batch of Yeezy sneakers after breakup with Ye

focus

knowledge

knowledge

Bright Health sells Medicare Advantage business to Molina

The biotech scorecard for Q1: 17 stock

Jerome Adams on the need for new antivirals for Covid

JPM: CVS says Medicare Advantage patients are impacting profits

How to save PrEP access — and even expand it

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Virginia high school admissions case could be legal follow

Trump team launching legal defense fund to help pay legal bills

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

focus

Judge orders hearing on Trump's motion to disqualify Fulton County DA

GSK Flovent asthma inhalers replaced by authorized generics

3 medical device trends to watch in 2024

Burning questions for the 2024 JPM Healthcare Conference

J&J to buy cancer drug developer Ambrx Biopharma

GSK Flovent asthma inhalers replaced by authorized generics

focus

leisure time

entertainment

explore